Search clinical trials for: Tarceva (erlotinib HCl, OSI-774)
Total 515 results
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedCarcinoma, Non-small-cell LungCanada, United States, Australia, Singapore, Israel, China, Argentina, Germany, Sweden, Brazil, Chile, Greece, Mexico, New Zealand, Romania, South Africa, Thailand
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
-
Astellas Pharma IncCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
Northwell HealthGenentech, Inc.CompletedGlioblastoma Multiforme | Anaplastic AstrocytomaUnited States
-
Montefiore Medical CenterGenentech, Inc.Completed
-
Pasi A. Janne, MD, PhDMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedAdenocarcinoma | Non-small Cell Lung CancerUnited States
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astellas Pharma US, Inc.Completed
-
M.D. Anderson Cancer CenterUnited States Department of DefenseCompletedLung CancerUnited States
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsTerminated
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
University Health Network, TorontoOSI PharmaceuticalsCompleted
-
University College, LondonRoche Pharma AG; Cancer Research UKTerminatedLung Cancer | Metastatic CancerUnited Kingdom
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsTerminated
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.CompletedCarcinoma, Non-small-cell LungUnited States
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLung CancerUnited Kingdom
-
Milton S. Hershey Medical CenterGenentech, Inc.CompletedPancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaboratorsCompletedBronchioloalveolar Cell Variant of Non-small Cell Lung CancerUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Heather WakeleeNovartis; Genentech, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC), Recurrent | Non-small Cell Lung Cancer (NSCLC), Stage IVUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-Small-Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterUnited States Department of DefenseCompletedLung CancerUnited States
-
M.D. Anderson Cancer CenterCompletedSolid Tumors | Advanced CancersUnited States
-
National Cancer Institute (NCI)CompletedFamilial Adenomatous Polyposis | Attenuated Familial Adenomatous PolyposisUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterCompleted
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; OSI PharmaceuticalsCompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsCompletedBrain Cancer | Non-small Cell Lung CancerUnited States
-
Washington University School of MedicineTerminatedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung CancerUnited States
-
St. Jude Children's Research HospitalDuke University; Rady Children's Hospital, San DiegoCompletedBrain and Central Nervous System TumorsUnited States
-
Fox Chase Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentUnited States
-
Guangdong Provincial People's HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor ReceptorChina
-
OSI PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedErlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerRecurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma | Recurrent Urethral Urothelial Carcinoma | Stage III Renal Pelvis Cancer AJCC v8 | Stage III Ureter Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage 0a Bladder Cancer... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Merck Sharp & Dohme LLC; Nova...Completed
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyCompleted
-
M.D. Anderson Cancer CenterCompleted
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astellas Pharma IncCompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI); Astellas Pharma Inc; Polyphenon PharmaCompletedCancer of Head and Neck | Neoplasms, Head and NeckUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedBreast CancerUnited States